METRNL 抑制糖尿病代谢应激下小鼠胰岛 β 细胞向 α 细胞转分化以维持 β 细胞功能
本研究在 β 细胞特异性敲除 Metrnl 的小鼠中,于普通饮食和高脂饮食条件下观察糖耐量、胰岛素分泌及胰岛基因表达,并用单细胞 RNA 测序分析细胞分化轨迹。结果显示 METRNL 缺失加重高脂饮食小鼠糖尿病和糖耐量异常,促进 β 细胞向 α 细胞转分化,而重组 METRNL 可改善高脂饮食和 db/db 小鼠的胰岛素抵抗及血浆胰岛素水平。
要点
- METRNL 主要表达于胰岛 β 细胞,在 db/db 或 HFD/链脲佐菌素诱导的糖尿病小鼠胰岛中表达降低。
- β 细胞 Metrnl 缺失破坏高脂饮食小鼠胰岛素分泌,加重糖尿病和糖耐量异常。
- 重组 METRNL 给药可改善 HFD 喂养和 db/db 小鼠的葡萄糖摄取、胰岛素抵抗及血浆胰岛素水平。
核心结论
- METRNL 有助于维持 β 细胞完整性,阻止 β 细胞向 α 细胞转分化,是代谢应激下 β 细胞代偿所必需,从而抑制糖尿病进展。
研究设计与样本
- 研究采用 β 细胞特异性 Metrnl 敲除小鼠,在普通饮食和高脂饮食条件下观察糖耐量、胰岛素分泌、胰岛基因表达及葡萄糖刺激的胰岛素分泌(GSIS)。
- 对分离胰岛进行单细胞 RNA 测序,分析细胞发育轨迹和细胞间相互作用;并检测重组 METRNL 补充对高脂饮食喂养或 db/db 小鼠的影响。
主要发现
- METRNL 主要表达于胰岛 β 细胞,在 db/db 或 HFD/链脲佐菌素诱导的小鼠胰岛中表达降低,且与这些糖尿病小鼠的胰岛素表达正相关。
- β 细胞 Metrnl 缺失破坏高脂饮食小鼠的胰岛素分泌,导致糖尿病和糖耐量异常加重;离体胰岛 GSIS 实验中胰岛素分泌减少。
- 单细胞 RNA 测序显示 METRNL 缺失与向 α 细胞分化的潜在演化关系相关,α 细胞基因(如 Gcg、Arx、Irx2)上调、β 细胞身份基因(如 Ins1、Ins2、Pdx1、Mafa)下调。
- METRNL 缺失通过损害 β 细胞能力促进代谢应激下 β 细胞向 α 细胞转分化,部分由于 c-Jun 水平升高;作为 KLF6 的关键执行者,METRNL 可能在维持代谢应激下 β 细胞完整性和功能中起重要作用。
- 重组 METRNL 给药显著改善 HFD 喂养和 db/db 小鼠的葡萄糖摄取、减轻胰岛素抵抗严重程度并增加血浆胰岛素水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: In type 2 diabetes mellitus, beta cell failure is associated with pancreatic beta cell dedifferentiation and trans-differentiation into other types of islet cells. However, the mechanisms underlying this process remain unclear. Recently, meteorin-like (METRNL) protein, a newly discovered secretory protein, has demonstrated beneficial effects in obesity and insulin resistance. However, its role in islet cell function, particularly in differentiated beta cells, remains to be elucidated. This study aims to investigate the effects of Metrnl gene deletion in beta cells on islet function and determine whether METRNL-mediated maintenance of islet cell identity is necessary for beta cell compensation in diabetes. METHODS: Mice with a specific deletion of Metrnl in beta cells were studied under both normal (chow diet) and metabolic stress (high-fat diet [HFD]) conditions. The investigation focused on their glucose tolerance, insulin secretion, islet gene expression and glucose-stimulated insulin secretion (GSIS). Additionally, cell developmental trajectory and cell-cell interaction analyses of the isolated islets were conducted using single-cell RNA-seq. Furthermore, the impact of METRNL replenishment on the regulation of beta cells in response to HFD feeding or in db/db mice was also examined. RESULTS: METRNL was predominantly expressed in islet beta cells. However, its expression was reduced in the islets of db/db or HFD/streptozocin-induced mice, which positively correlated with insulin expression in these diabetic mice. Furthermore, the deletion of Metrnl in beta cells disrupted insulin secretion in mice fed with HFD, resulting in worsened diabetes and glucose intolerance. Pancreatic islets isolated from METRNL-deficient mice also exhibited reduced insulin secretion in GSIS assays in vitro. Additionally, single-cell RNA-seq analysis of isolated islets demonstrated that METRNL deficiency in beta cells was associated with a potential evolutionary differentiation relationship, indicating a trajectory toward alpha cells. This beta-to-alpha cell trans-differentiation was further evidenced by the upregulation of alpha cell genes (e.g. Gcg, Arx and Irx2) and downregulation of beta cell identity genes (e.g. Ins1, Ins2, Pdx1, and Mafa). Furthermore, METRNL deficiency was found to promote beta-to-alpha cell trans-differentiation during metabolic stress by impairing beta cell capacity, partially due to increased c-Jun levels. On the other hand, as a crucial executor of Kruppel-like transcription factor 6 (KLF6), METRNL may play an important role in maintaining beta cell integrity and function under metabolic stress. Moreover, recombinant METRNL administration significantly improved glucose uptake, lessened the severity of insulin resistance and increased plasma insulin levels in both HFD-fed and db/db mice. CONCLUSIONS/INTERPRETATION: METRNL helps to maintain beta cell integrity, preventing beta-to-alpha cell trans-differentiation, and is necessary for beta cell compensation under metabolic stress, thereby inhibiting the progression of diabetes. DATA AVAILABILITY: scRNA-seq data are accessible via the NCBI Sequence Read Archive ( http://www.ncbi.nlm.nih.gov/bioproject/ ) under accession no. PRJNA1224190. Original western blotting analysis is publicly available in the figshare repository, as part of this record: https://doi.org/10.6084/m9.figshare.28379006 .
引用
- Zhou Y, Hu L, Zhuang R, et al. METRNL represses beta-to-alpha cell trans-differentiation to maintain beta cell function under diabetic metabolic stress in mice. Diabetologia. 2025. PMID: 40495021. doi:10.1007/s00125-025-06459-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。